SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Leerink Partners Cuts NeuroPace to Market Perform From Outperform

Leerink Partners cut its rating on NeuroPace to Market Perform from Outperform and announced a $7.00-per-share price target.

NPCE

Related stories